Dr. Soliman Abdel Kader Fakeeh Hospital Company

SASE:4017 Stock Report

Market Cap: ر.س13.5b

Dr. Soliman Abdel Kader Fakeeh Hospital Past Earnings Performance

Past criteria checks 2/6

Dr. Soliman Abdel Kader Fakeeh Hospital has been growing earnings at an average annual rate of 1.1%, while the Healthcare industry saw earnings growing at 18.7% annually. Revenues have been growing at an average rate of 20.8% per year. Dr. Soliman Abdel Kader Fakeeh Hospital's return on equity is 7.7%, and it has net margins of 10.6%.

Key information

1.1%

Earnings growth rate

-20.7%

EPS growth rate

Healthcare Industry Growth12.3%
Revenue growth rate20.8%
Return on equity7.7%
Net Margin10.6%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Dr. Soliman Abdel Kader Fakeeh Hospital makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SASE:4017 Revenue, expenses and earnings (SAR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 242,5862743460
31 Mar 242,4782803230
31 Dec 232,3272803040
30 Sep 232,2053112340
31 Dec 222,0123261980
31 Dec 211,9653342310
31 Dec 201,7152032030
31 Dec 191,6403012380

Quality Earnings: 4017 has high quality earnings.

Growing Profit Margin: 4017's current net profit margins (10.6%) are lower than last year (14.8%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 4017's earnings have grown by 1.1% per year over the past 5 years.

Accelerating Growth: 4017's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 4017 had negative earnings growth (-13.3%) over the past year, making it difficult to compare to the Healthcare industry average (36.5%).


Return on Equity

High ROE: 4017's Return on Equity (7.7%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies